About 10 Trademarks found that are owned by Wave Life Sciences Ltd

Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing

Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing

"LIFE SCIENCES"

Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine and nucleic acid therapeutics; research, development and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals

"LIFE SCIENCES"

Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine and nucleic acid therapeutics; research, development and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals

The mark consists of the stylized word "WAVE" appearing in larger text above the smaller stylized words "LIFE SCIENCES".

Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders

The mark consists of the stylized letter "W".

Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders

The mark consists of the stylized letter "W" in gradient shades of dark blue to light blue and dark purple to pink.

Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders

Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders

Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders

Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease; nucleic acid therapeutic agents and pharmaceutical preparations for the prevention, treatment and diagnosis of neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, and Huntington's disease; pharmaceutical preparations for the prevention, treatment and diagnosis of immune disorders, namely, psoriasis, rheumatoid arthritis, lupus, Crohn's disease, inflammatory bowel disease, and multiple sclerosis; pharmaceutical preparations for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders

"THERAPEUTICS"